Vault-13

AESTHETIC MED INTL HLDG GR L PAIYY

ADS · ADR · CUSIP 00809M104

6 institutional holders +0 vs Q1 2023
579,610579.6k shares reported held*
$605.6kreported value*
1 new 0 added 1 reduced 1 sold out net bought ≈ $12.2k (+11.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.04.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

0246Q3 22: 6Q4 22: 6Q1 23: 6Q2 23: 66Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 20226
Q4 20226
Q1 20236
Q2 20236

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
202Q4 22: 1 bought or addedQ4 22: 1 cut or sold outQ4 22Q1 23: 1 bought or addedQ1 23: 2 cut or sold outQ1 23Q2 23: 1 bought or addedQ2 23: 2 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 202211
Q1 202312
Q2 202312

Biggest buyers

RHUMBLINE ADVISERS New +11,995+12.0k

Biggest sellers

RENAISSANCE TECHNOLOGIES LLC Reduced -300-300
UBS Group AG Sold out -33-33

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Hainan Oriental Jiechuang Investment Partnership (Limited Pa 13D · may seek influence filed 2026-04-03
Stated purposeOn July 20, 2022, certain parties entered into the respective agreements as below: (i) the Issuer, Dr. Zhou Pengwu, Ms. Ding Wenting (together with Dr. Zhou Pengwu, the "Founders") and Jiechuang entered into a Share Subscription Agreement (the "Jiechuang Agreement") whereby Jiechuang or its designated entity agrees to subscribe 36,402,570 newly issued ordinary shares of the Issuer for the equivalent US dollars of RMB170,000,000; (ii) the Issuer, Seefar Global Holdings Limited ("Seefar"), Jubilee Set Investments Limited ("Jubilee"), Pengai Hospital Management Corporation ("PH Management", together with Seefar and Jubilee, the "Sellers"), the Founders and Wanda entered into a Share Purchase Agreement (the "Wanda Agreement") whereby Wanda agrees to purchase 21,321,962 shares of ordinary sha… Full filing
 37.6% 57.8m 2026-04-03

Insider purchases and sales in Q2 2023

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q2 2023.

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 IDG Technology Venture Investment IV, LLC 0.34% of their portfolio Hong Kong, K3 396,086396.1k $415.9k $415.9k 0.34% Unchanged
2 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 156,529156.5k $161.2k $161.2k 0.00% Unchanged
3 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 13,00013.0k $14.0k $14.0k 0.00% Reduced -300 -300
4 RHUMBLINE ADVISERS 0.00% of their portfolio BOSTON, MA 11,99512.0k $12.4k $12.4k 0.00% New
5 Nordwand Advisors, LLC 0.00% of their portfolio RADNOR, PA 2,0002.0k $2.1k $2.1k 0.00% Unchanged
6 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged